Drug profile · INN
desipramine hydrochloride
DESIPRAMINE HYDROCHLORIDE
desipramine hydrochloride (DESIPRAMINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — desipramine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
desipramine hydrochloride (DESIPRAMINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is desipramine hydrochloride?
desipramine hydrochloride (DESIPRAMINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for desipramine hydrochloride?
DESIPRAMINE HYDROCHLORIDE is a marketed brand name for desipramine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desipramine hydrochloride?
desipramine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.